Schedule 13G ownership disclosure

Janux Therapeutics Inc

Security class unavailable · CUSIP: 47103J105

Event date: 2023-01-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,255,270
Percent of class
7.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-23-000053
Form type
SC 13G
Filer
EcoR1 Capital, LLC
CIK
CIK 1587114
Filed
Jan 23, 2023
Reporting period
Jan 10, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub